Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer

BACKGROUND: Pancreatic cancer is aggressive with no symptoms until the advanced stage reached. The increased resistance of pancreatic cancer to chemotherapy demonstrates a dilemma in the clinical field. Hence, it is a matter of great urgency to develop an effective drug to treat patients with pancre...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yangyang, Zhu, Hengyue, Weng, Min, Wang, Cheng, Sun, Linxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282238/
https://www.ncbi.nlm.nih.gov/pubmed/32513155
http://dx.doi.org/10.1186/s12906-020-02976-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282238/
https://www.ncbi.nlm.nih.gov/pubmed/32513155
http://dx.doi.org/10.1186/s12906-020-02976-7

Ejemplares similares